HHS cancels fourth USPSTF meeting in a row

White House regulatory priorities include “aggressive” HHS agenda

The White House Office for Regulatory Affairs and Information released a series of documents detailing each agency’s regulatory priorities for the coming year.

Breaking down Operation Trailblazer: Rolling INDs, outside expert submission help, and one-trial requirement

In this week’s episode of The Cancer Letter Podcast, Paul Goldberg, editor and publisher of The Cancer Letter, and Sara Willa Ernst, reporter, break down HHS’ latest vision for the future: Operation Trailblazer.

July 01, 2026

Regulatory News

To keep the early clinical trial enterprise in the U.S., HHS pledges to simplify regulatory requirements

HHS earlier this week rolled out a cluster of initiatives related to simplifying clinical trials, presenting these measures as a government-wide effort to maintain America’s leadership in early-stage drug development.

Protect the integrity of USPSTF, patient and provider groups urge in letter to Kennedy

In a letter, sixty organizations representing cancer patients and providers are urging HHS Secretary Robert F. Kennedy Jr. to maintain the integrity of the U.S. Preventive Task Force.

May 29, 2026

Vol.52 No.21

By Claire Marie Porter

Kennedy calls for a “moonshot” targeted on the role of the microbiome in cancer

Top HHS officials last week called for a “moonshot” focused on the role of the microbiome in cancer.

HHS rescinds vaccine panel charter citing “administrative error”

The charter governing the Advisory Committee on Immunization Practices will be returned to its previous framework for two years because the Department of Health and Human Services didn’t allow sufficient time for public comment after Robert F. Kennedy crafted a charter more favorable to his policy preferences.

May 22, 2026

Vol.52 No.20

By Claire Marie Porter